|
|
Post by mango on Oct 31, 2017 12:25:36 GMT -5
Happy Halloween! Two New Granted MannKind Patents Published 10/31/2017 Potentiation of glucose eliminationType: Grant Filed: March 5, 2015 Date of Patent: October 31, 2017 Assignee: MannKind Corporation Inventors: Anders Hasager Boss, Solomon S. Steiner, Rodney J. Woods, Joseph W. Sulner patents.justia.com/patent/9801925Dry powder drug delivery system and methodsType: Grant Filed: July 12, 2013 Date of Patent: October 31, 2017 Assignee: MannKind Corporation Inventors: Chad C. Smutney, Benoit Adamo, Brendan F. Laurenzi, P. Spencer Kinsey patents.justia.com/patent/9802012 |
|
|
|
Post by mango on Nov 3, 2017 13:23:59 GMT -5
New International MannKind Patent Application Published 10/26/2017 Application Date: 03.07.2017 Publication Date: 26.10.2017 Applicants: MannKind Corporation Inventors: Donald Costello Peter Richardson Robert A. Baughman Mark T. Marino Title: (EN) METHOD FOR TREATING HYPERGLYCEMIA WITH GLP-1 Abstract: (EN) A method for treating hyperglycemia and/or diabetes in a subject is provided. In particular, the method is directed for the treatment of patients with type 2 diabetes mellitus who have a fasting blood glucose concentration greater than about 8 mM, wherein the patient is administered a formulation comprising a GLP-1 molecule and a diketopiperazine by pulmonary inhalation with a dry powder inhalation system patentscope.wipo.int/search/en/detail.jsf?docId=US205400483 |
|
|
|
Post by mango on Nov 9, 2017 11:02:16 GMT -5
Two New International MannKind Patents 1. Application Date: 30.09.2013 Publication Date: 31.10.2017 Grant Date: 31.10.2017 Applicants: MANNKIND CORPORATION MICHAEL S. BERGEY Inventors: MICHAEL S. BERGEY Title: (HE) שלפוחיות עבור תרופה (BLISTER PACKAGE FOR PHARMACEUTICAL CARTRIDGES) Abstract: (EN) patentscope.wipo.int/search/en/detail.jsf?docId=IL205749697 2. Application Date: 14.09.2006 Publication Date: 02.11.2017 Applicants: MannKind Corporation Inventors: Oberg, Keith A Title: (ES) Método de formulación de fármacos basado en el aumento de la afinidad de superficies de micropartículas cristalinas para agentes activos (Drug formulation method based on increased affinity of crystalline microparticle surfaces for active agents) Abstract:patentscope.wipo.int/search/en/detail.jsf?docId=ES205691526 |
|
|
|
Post by kite on Nov 9, 2017 11:05:32 GMT -5
Two New International MannKind Patents 1. Application Date: 30.09.2013 Publication Date: 31.10.2017 Grant Date: 31.10.2017 Applicants: MANNKIND CORPORATION MICHAEL S. BERGEY Inventors: MICHAEL S. BERGEY Title: (HE) שלפוחיות עבור תרופה (BLISTER PACKAGE FOR PHARMACEUTICAL CARTRIDGES) Abstract: (EN) patentscope.wipo.int/search/en/detail.jsf?docId=IL205749697 2. Application Date: 14.09.2006 Publication Date: 02.11.2017 Applicants: MannKind Corporation Inventors: Oberg, Keith A Title: (ES) Método de formulación de fármacos basado en el aumento de la afinidad de superficies de micropartículas cristalinas para agentes activos (Drug formulation method based on increased affinity of crystalline microparticle surfaces for active agents) Abstract:patentscope.wipo.int/search/en/detail.jsf?docId=ES205691526South America (Brazil) and ...? Which two countries? |
|
|
|
Post by peppy on Nov 9, 2017 11:07:48 GMT -5
Hebrew, so Israel?
|
|
|
|
Post by kite on Nov 9, 2017 11:17:04 GMT -5
Looks like the Middle East to me! Not that I'm speculating anything... |
|
|
|
Post by mango on Nov 9, 2017 13:41:42 GMT -5
|
|
|
|
Post by mango on Nov 16, 2017 12:09:00 GMT -5
|
|
|
|
Post by mango on Nov 23, 2017 21:43:45 GMT -5
New International MannKind Patent Application Published 11/23/2017 This patent is for the Bluetooth inhaler. International Filing Date: 19.05.2017 Publication Date: 23.11.2017 Applicants: MANNKIND CORPORATION [US/US] Inventors: POCREVA III, John, J.; (US) ADAMO, Benoit; (US) LAURENZI, Brendan; (US) SMUTNEY, Chad, C.; (US) KINSEY, P., Spencer; (US) Title (EN) APPARATUS, SYSTEM AND METHOD FOR DETECTING AND MONITORING INHALATIONS Abstract: (EN) Described herein are an interactive apparatus and methods for sensing and measuring real-time characteristic patterns of a subject's use of a dry powder inhalation system. The inhaler device can be used in a wireless communication mode to communicate with a display to assess the subject's usage of the inhalation system concurrently as the inhalation is performed and thus the subject's inhalation can be evaluated as well as the performance of the inhalation system. The system can also detect the identity of the medicament, its dosage, lot, expiration, etc. and the characteristics profile of a dry powder formulation emitted from the inhalation system in use. 26. The method of claim 25 wherein the wireless transmission comprises Bluetooth®, Zigbee®; WiFi, SmartWave, or Z-Wave. MannKind Bluetooth Inhaler Patent |
|
|
|
Post by mango on Nov 24, 2017 2:19:45 GMT -5
This smart inhaler is going to be equiped with numerous capabilities and applications. One of them I think is pretty cool is this little mountable accessory, like a jacket, that is a touch screen. Can't wait to see what the final device looks like. The inhaler provides real-time data. This will complement the real-time capabilities of CGMs nicely. MannKind has some exciting times ahead and 2018 could be their year. Passion, patience and persistence is key.   |
|
|
|
Post by mytakeonit on Nov 24, 2017 12:48:41 GMT -5
And how much is this inhaler supposed to cost? Think we should stick with what we have ... this is way over kill. IMO
|
|
|
|
Post by madog365 on Nov 24, 2017 14:13:54 GMT -5
Just think about the future of diabetes care:
Your bloodsugar will be automatically monitored and added via a cgm into your one drop diabetes app
you will then use a bluetooth inhaler filled with afrezza to take your insulin
the inhaler will automatically add your dosage into the one drop app as well as when you took the dose and how your bs responded
|
|
|
|
Post by mytakeonit on Nov 24, 2017 14:17:49 GMT -5
Yeah you're right maddog ... let's go for it!
|
|
|
|
Post by akemp3000 on Nov 24, 2017 14:26:09 GMT -5
This inhaler is quite interesting. When a few people have suggested another new drug might come along some day to compete with Afrezza, I've maintained that there's really no space for new drug improvement as Afrezza already mimics a healthy pancreas. The space that does exist for improvement is real-time, calibrated titration of the amount of Afrezza that's needed. It looks like this may be addressed by Mannkind and One Drop. If so, results will likely prove once and for all that Afrezza is a generation ahead of the other current drug options.
|
|
|
|
Post by mango on Nov 24, 2017 14:37:49 GMT -5
This inhaler is quite interesting. When a few people have suggested another new drug might come along some day to compete with Afrezza, I've maintained that there's really no space for new drug improvement as Afrezza already mimics a healthy pancreas. The space that does exist for improvement is real-time, calibrated titration of the amount of Afrezza that's needed. It looks like this may be addressed by Mannkind and One Drop. If so, results will likely prove once and for all that Afrezza is a generation ahead of the other current drug options. Exactly. Over the top is required in this cut throat world, especially in this situation where greed sits in the way of getting people with diabetes the help they need and putting an end to this epidemic. Why wouldn't someone want the world to be a better place? |
|
